Hit enter to search or ESC to close

Investor Centre
Archive

Investor Resources

Investor presentations

ASX Announcements

2019

2018

2017

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

Financial reports

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

Corporate governance

News

Quarterly Cash Flow Report

Highlights: Completion of Phase 1 Clinical Trial; PBT434 found to be safe and well-tolerated; clinically tested doses achieve concentrations

Read More
Quarterly Cash Flow Report

Highlights: Results of Phase 1 Clinical Trials for lead compound PBT434 announced Presentation of clinical trial data at the 2019 Internatio

Read More

Receive news from Alterity Therapeutics